Skip to main content
TipRanks
Go Ultimate75% OFF

Central Reinsurance Corporation (2851) AI Stock Analysis

TW:2851

Central Reinsurance Corporation

(TWSE:2851)

Select Model
Rating:81Outperform
Price Target:TWD 54.00â–²(16.76% Upside)
Action:initiatedcoverage
Date:11/10/26

The score is supported primarily by strong financial performance and attractive valuation, including minimal debt, improving profitability, and a high dividend yield. Mixed technical momentum and recent cash-flow volatility limit the upside assessment.

Positive Factors
Conservative LeverageAn exceptionally conservative capital structure materially reduces financial risk and interest-related pressure. Strong capitalization gives Central Reinsurance greater resilience through adverse underwriting or investment periods, while preserving flexibility to support operations and absorb losses over the next several quarters.
Negative Factors
Volatile Cash GenerationThe sharp swings in free cash flow show that reported profitability does not consistently translate into cash generation from year to year. This instability can complicate capital planning, dividend decisions, and reinvestment, even though the strong 2025 rebound provides evidence of recovery.

Central Reinsurance Corporation (2851) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%TW:2851+85.52%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 36.62B
Dividend Yield
4.76%
Average Volume (3M)
3.48M
Price to Earnings (P/E)
4.4
Beta (1Y)
0.31
Revenue Growth
21.22%
EPS Growth
481.08%
Country
TW
Employees
177
Sector
General
Sector Strength
55
Industry
Insurance - Reinsurance

Central Reinsurance Corporation Business Overview & Revenue Model

Company Description

Central Reinsurance Corporation operates both domestically in Taiwan and across international markets, providing a comprehensive suite of life and non-life insurance solutions. Its non-life offerings encompass protection against fire, marine and avia...

Central Reinsurance Corporation Financial Statement Overview

Summary

Strong financial profile, led by a very strong balance sheet, improved profitability, and recovering free cash flow. Historical cash-flow volatility and modest revenue growth temper the score.

Income Statement

86Very Positive

Balance Sheet

94Very Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue25.85B22.90B22.89B21.98B21.34B20.44B
Gross Profit17.88B16.93B17.12B16.18B16.12B14.85B
EBITDA9.77B3.43B2.99B2.52B45.05M2.48B
Net Income8.45B2.93B2.52B2.09B253.27M2.07B
Balance Sheet
Total Assets65.43B59.84B57.85B53.90B50.27B49.46B
Cash, Cash Equivalents and Short-Term Investments20.11B12.49B11.70B14.49B21.85B17.29B
Total Debt279.00K463.00K824.00K1.29M1.82M1.35M
Total Liabilities39.12B38.13B36.95B34.84B33.27B32.91B
Stockholders Equity26.30B21.71B20.90B19.05B17.00B16.55B
Cash Flow
Free Cash Flow12.71B2.32B-1.75B-7.37B2.09B3.16B
Operating Cash Flow12.73B2.36B-1.73B-7.33B2.12B3.17B
Investing Cash Flow2.30M-1.39M-19.46M-33.83M-33.64M-15.40M
Financing Cash Flow-1.52B-1.52B-1.12B-536.00K2.25B-767.91M

Central Reinsurance Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:2851 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:2851TW:285181OutperformTWD 35.94B4.42―4.76%21.22%481.08%
TW:2850TW:285073OutperformTWD 48.82B10.12―4.65%21.66%45.77%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%25%50%75%100%TW:2851TW:2850Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:2851 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:2851Central Reinsurance Corporation46.2521.6087.64%
TW:2850Shinkong Insurance Co., Ltd.156.5044.7740.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026